Omega Fund Management, LLC Paratek Pharmaceuticals, Inc. Transaction History

Omega Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.07 - $5.3 $2.59 Million - $3.37 Million	-635,568 Reduced 24.38%	1,971,241 $8.85 Million
Q3 2021 Nov 15, 2021	BUY	$4.7 - $7.24 $30,075 - $46,328	6,399 Added 0.25%	2,606,809 $12.7 Million
Q3 2020 Nov 16, 2020	SELL	$4.19 - $6.69 $9,758 - $15,581	-2,329 Reduced 0.09%	2,600,410 $14.1 Million
Q2 2020 Aug 17, 2020	BUY	$2.97 - $5.22 $6,917 - $12,157	2,329 Added 0.09%	2,602,739 $13.6 Million
Q3 2017 Nov 03, 2017	BUY	$18.9 - $28.2 $49.1 Million - $73.3 Million	2,600,410	2,600,410 $65.3 Million

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Omega Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Omega Fund Management, LLC with notifications on news.